The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 14, 2025
Filed:
Nov. 10, 2021
Applicant:
California Institute of Technology, Pasadena, CA (US);
Inventors:
Alexander A. Cohen, Pasadena, CA (US);
Pamela J. Bjorkman, Altadena, CA (US);
Assignee:
California Institute of Technology, Pasadena, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/215 (2006.01); A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61P 31/14 (2006.01); A61P 37/04 (2006.01); C07K 14/165 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/215 (2013.01); A61K 39/385 (2013.01); A61K 39/39 (2013.01); A61P 31/14 (2018.01); A61P 37/04 (2018.01); C07K 14/165 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/70 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01);
Abstract
Disclosed herein include multivalent carriers comprising a plurality of heterologousproteins antigens derived from differentThe multivalent carriers herein described can elicit heterologous binding and neutralization properties againstthat differ from thefrom which theantigens are derived to produce the multivalent carriers. Also provided herein include vaccine compositions comprising the multivalent carriers and related methods using the vaccine compositions in various therapeutic and prophylactic applications.